Using high-throughput functional RNA interference (RNAi), Cerone et al. revealed that MAPK15 is a novel regulator of telomerase, whose inhibition reduces telomerase activity and elicits characteristics of telomere dysfunction in cancer cells [8]. The gene discussed is MAPK15; the disease is cancer.